FDA approves potential COVID-19 vaccine by Moderna for second-stage study - UPI.com
mRNA vaccines — a new era in vaccinology | Nature Reviews Drug Discovery
SARS-CoV-2 mRNA Vaccine Development Enabled by Prototype Pathogen Preparedness | bioRxiv
Delivering the Messenger: Advances in Technologies for Therapeutic mRNA Delivery - ScienceDirect
Moderna's coronavirus vaccine trial is fully enrolled, 37 percent of participants are minorities - The Washington Post
COVID-19 vaccine development and a potential nanomaterial path forward | Nature Nanotechnology
Frontiers | Current Efforts in the Development of Vaccines for the Prevention of Zika and Chikungunya Virus Infections | Immunology
A Single Immunization with Nucleoside-Modified mRNA Vaccines Elicits Strong Cellular and Humoral Immune Responses against SARS-C
mRNA vaccines - a new era in vaccinology. - Abstract - Europe PMC
Moderna's coronavirus vaccine shows encouraging early results - The Washington Post
SARS-CoV-2 mRNA Vaccine Development Enabled by Prototype Pathogen Preparedness | bioRxiv
Moderna Therapeutics — Wikipédia
SARS-CoV-2 mRNA Vaccine Development Enabled by Prototype Pathogen Preparedness | bioRxiv
Moncef Slaoui - Wikipedia
mRNA vaccines - a new era in vaccinology. - Abstract - Europe PMC
SARS-CoV-2 mRNA Vaccine Development Enabled by Prototype Pathogen Preparedness | bioRxiv
A Single Immunization with Nucleoside-Modified mRNA Vaccines Elicits Strong Cellular and Humoral Immune Responses against SARS-CoV-2 in Mice. - Abstract - Europe PMC
A Single Immunization with Nucleoside-Modified mRNA Vaccines Elicits Strong Cellular and Humoral Immune Responses against SARS-C
COVID-19 tracker: Regeneron's antibody cocktail hit by safety concerns; Novo's Rybelsus emerging from pandemic slump | FiercePharma
mRNA vaccines - a new era in vaccinology. - Abstract - Europe PMC
Delivering the Messenger: Advances in Technologies for Therapeutic mRNA Delivery - ScienceDirect
SARS-CoV-2 mRNA Vaccine Development Enabled by Prototype Pathogen Preparedness | bioRxiv
Preclinical and Clinical Demonstration of Immunogenicity by mRNA Vaccines against H10N8 and H7N9 Influenza Viruses: Molecular Therapy
PDF) mRNA vaccines — a new era in vaccinology
SARS-CoV-2 mRNA Vaccine Development Enabled by Prototype Pathogen Preparedness | bioRxiv
SARS-CoV-2 mRNA Vaccine Development Enabled by Prototype Pathogen Preparedness | bioRxiv
